Pentaxim primary infant vaccination schedules versus separate DTaP, Hib, and IPV vaccines in China

Phase 3 trial of diphtheria toxoid + tetanus toxoid + acellular pertussis vaccine + inactivated poliovirus vaccine + haemophilus influenzae type b conjugate vaccine, Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen, inactivated poliovirus vaccine and diphtheria, tetanus, and acellular pertussis vaccine in Haemophilus influenzae type b disease (Hib), poliomyelitis, diphtheria and 2 more (3 arms), sponsored by Sanofi. Primary endpoints: Seroprotection non-inferiority after primary vaccination, Pertussis immune response non-inferiority after primary vaccination and 1 more.